Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1973 2
1974 1
1976 1
1977 1
1980 2
1983 2
1985 1
1994 1
1995 1
1996 3
1997 1
1998 1
2000 3
2001 4
2002 1
2003 1
2011 1
2012 3
2014 2
2015 1
2016 1
2017 2
2018 2
2019 1
2020 1
2022 1
2023 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

39 results

Results by year

Filters applied: . Clear all
Page 1
Mast cell sarcoma: clinical management.
Weiler CR, Butterfield J. Weiler CR, et al. Immunol Allergy Clin North Am. 2014 May;34(2):423-32. doi: 10.1016/j.iac.2014.01.004. Epub 2014 Mar 13. Immunol Allergy Clin North Am. 2014. PMID: 24745684 Review.
Mast cell sarcoma is a disorder that results in abnormal mast cells as identified by morphology, special stains, and in some publications, c-kit mutation analysis. ...It is occasionally associated with systemic mastocytosis and/or urticaria pigmentosa. The pr …
Mast cell sarcoma is a disorder that results in abnormal mast cells as identified by morphology, special stains, and in …
Pathology of extramedullary mastocytosis.
Doyle LA, Hornick JL. Doyle LA, et al. Immunol Allergy Clin North Am. 2014 May;34(2):323-39. doi: 10.1016/j.iac.2014.01.010. Immunol Allergy Clin North Am. 2014. PMID: 24745677 Review.
Systemic mastocytosis--a systematic review.
Andersen CL, Kristensen TK, Severinsen MT, Møller MB, Vestergaard H, Bergmann OJ, Hasselbalch HC, Bjerrum OW. Andersen CL, et al. Dan Med J. 2012 Mar;59(3):A4397. Dan Med J. 2012. PMID: 22381091 Free article. Review.
METHODS: A search was made in PubMed in August 2011 entering the keywords: mastocytosis, (systemic, cutaneous, aggressive), mast cell leukaemia, mast cell sarcoma, chromosome, mutation, haematology and treatment. ...
METHODS: A search was made in PubMed in August 2011 entering the keywords: mastocytosis, (systemic, cutaneous, aggressive), mast cell leukae …
Natural history and treatment of cutaneous and systemic mastocytosis.
Le M, Miedzybrodzki B, Olynych T, Chapdelaine H, Ben-Shoshan M. Le M, et al. Postgrad Med. 2017 Nov;129(8):896-901. doi: 10.1080/00325481.2017.1364124. Epub 2017 Aug 21. Postgrad Med. 2017. PMID: 28770635 Review.
INTRODUCTION: Mastocytosis, a heterogeneous group of disorders, is characterized by an abnormal increase in the number of mast cells that is limited to the skin (cutaneous mastocytosis), involving extracutaneous tissues (systemic mastocytosis), or presenting as solid tumours (mas …
INTRODUCTION: Mastocytosis, a heterogeneous group of disorders, is characterized by an abnormal increase in the number of mast cells that is …
Mastocytosis.
Fine J. Fine J. Int J Dermatol. 1980 Apr;19(3):117-23. doi: 10.1111/j.1365-4362.1980.tb00272.x. Int J Dermatol. 1980. PMID: 6156134 Review.
Mast cell neoplasm: a challenging pathological diagnosis.
Natal RA, Carneiro HC, de Carvalho Barra FF, Pagnano KBB, Soares FA, Vassallo J. Natal RA, et al. Hum Pathol. 2022 Aug;126:55-62. doi: 10.1016/j.humpath.2022.05.007. Epub 2022 May 10. Hum Pathol. 2022. PMID: 35550832
Ten patients were classified as aggressive SM, one patient as SM with an associated acute promyelocytic leukemia with t(15;17), and one patient with mast cell sarcoma. The most common clinical findings included anemia (9 patients), thrombocytopenia (3 patient …
Ten patients were classified as aggressive SM, one patient as SM with an associated acute promyelocytic leukemia with t(15;17), and one pati …
Update on Mastocytosis (Part 2): Categories, Prognosis, and Treatment.
Azaña JM, Torrelo A, Matito A. Azaña JM, et al. Actas Dermosifiliogr. 2016 Jan-Feb;107(1):15-22. doi: 10.1016/j.ad.2015.09.009. Epub 2015 Oct 30. Actas Dermosifiliogr. 2016. PMID: 26525106 Free article. Review. English, Spanish.
The systemic variants in this classification are as follows: indolent systemic mastocytosis (SM), aggressive SM, SM with an associated clonal hematological non-mast cell lineage disease, mast cell leukemia, mast cell sarcoma, and extracutaneous mastocytoma. T …
The systemic variants in this classification are as follows: indolent systemic mastocytosis (SM), aggressive SM, SM with an associated clona …
Comprehensive mastocytosis data analysis from a single center.
Tiryaki TO, Özkan SG, Erdem S, Aday AD, Hindilerden İY, Gelincik A, Baykal C, Yegen G, Doğan İÖ, Büyükbabani N, Nalçacı M, Yavuz AS. Tiryaki TO, et al. BMC Cancer. 2023 Jan 24;23(1):82. doi: 10.1186/s12885-022-10498-3. BMC Cancer. 2023. PMID: 36694141 Free PMC article.
Mastocytosis is a very rare disorder and is divided into three prognostically distinct variants by World Health Organization: Cutaneous mastocytosis (CM), systemic mastocytosis (SM), and mast cell sarcoma or localized mast cell (MC) tumors. The wide range of …
Mastocytosis is a very rare disorder and is divided into three prognostically distinct variants by World Health Organization: Cutaneous mast …
39 results